These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24906610)

  • 1. Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low toxicity agents.
    McCarty M; Fivenson D
    J Am Acad Dermatol; 2014 Sep; 71(3):475-9. PubMed ID: 24906610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
    Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
    J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful monotherapy of pemphigus vegetans with minocycline and nicotinamide.
    von Köckritz A; Ständer S; Zeidler C; Metze D; Luger T; Bonsmann G
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):85-88. PubMed ID: 27600093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Kowalewski C; Wozniak K
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral pemphigus vulgaris. Successful treatment with minocycline and nicotinamide].
    Häusermann P; Gutersohn T; Beltraminelli H; Schiller P; Büchner SA; Rufli T
    Hautarzt; 2002 Dec; 53(12):813-5. PubMed ID: 12444523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.
    Reguiai Z; Tabary T; Maizières M; Bernard P
    J Am Acad Dermatol; 2012 Oct; 67(4):623-9. PubMed ID: 22261417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs.
    White SD; Rosychuk RA; Reinke SI; Paradis M
    J Am Vet Med Assoc; 1992 May; 200(10):1497-500. PubMed ID: 1535346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report.
    Berk MA; Lorincz AL
    Arch Dermatol; 1986 Jun; 122(6):670-4. PubMed ID: 2940979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore.
    Goon AT; Tan SH; Khoo LS; Tan T
    Singapore Med J; 2000 Jul; 41(7):327-30. PubMed ID: 11026799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide and tetracycline therapy of bullous pemphigoid.
    Fivenson DP; Breneman DL; Rosen GB; Hersh CS; Cardone S; Mutasim D
    Arch Dermatol; 1994 Jun; 130(6):753-8. PubMed ID: 8002646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients.
    Tran KD; Wolverton JE; Soter NA
    Br J Dermatol; 2013 Oct; 169(4):916-21. PubMed ID: 23772610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
    Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
    Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Pemphigus senilis with tetracycline plus nicotinamide: long term follow-up.
    Fimiani M; Rubegni P; Flori ML; De Aloe G; Andreassi L
    J Am Geriatr Soc; 1997 Feb; 45(2):256-8. PubMed ID: 9033539
    [No Abstract]   [Full Text] [Related]  

  • 17. Oropharyngeal pemphigus vulgaris and clinical remission: a long-term, longitudinal study.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E
    Am J Clin Dermatol; 2010; 11(2):137-45. PubMed ID: 20141235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pemphigus herpetiformis with minocycline and nicotinamide.
    Wu C; Zuo Y; Jin H; Chen J; Li L
    Chin Med J (Engl); 2014; 127(19):3514. PubMed ID: 25269925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical Analysis of Eight Cases of Pemphigus with High Titers of Anti-desmoglein Antibodies in Remission].
    Jin XX; Li SZ; Zuo YG; Jin HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):166-172. PubMed ID: 33966693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.
    Green MG; Bystryn JC
    Arch Dermatol; 2008 Dec; 144(12):1621-4. PubMed ID: 19075146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.